4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-058458
Chief Financial Officer bought 11,829 shares at an average $0.95 ($11,241)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quinn William P. Chief Financial Officer | 2023-06-06 | Purchase | +1,829 | $1.18 | $2,161 | 26,272 | D |
| Quinn William P. Chief Financial Officer | 2023-12-06 | Purchase | +2,500 | $0.78 | $1,955 | 28,772 | D |
| Quinn William P. Chief Financial Officer | 2023-12-12 | Purchase | +7,500 | $0.95 | $7,125 | 36,272 | D |
| Open-market purchases · 11,829 sh · avg $0.95 · $11,241 | |||||||
Loading xslF345X05/doc4.xml…